HER2 AMPLIFICATION

Clinical trials for HER2 AMPLIFICATION explained in plain language.

Never miss a new study

Get alerted when new HER2 AMPLIFICATION trials appear

Sign up with your email to follow new studies for HER2 AMPLIFICATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested in fight against Tough-to-Treat cancers

Disease control Ongoing

This early-stage study is testing the safety and best dose of a new drug, ELVN-002, when given with standard treatments for advanced HER2-positive cancers. It will involve about 275 adults with cancers like breast, colorectal, or gastric cancer that have spread or returned after …

Matched conditions: HER2 AMPLIFICATION

Phase: PHASE1 • Sponsor: Enliven Therapeutics • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

HER2 AMPLIFICATION

Get alerted when new HER2 AMPLIFICATION trials appear

New drug combo tested in fight against Tough-to-Treat cancers